A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease (Cop1CD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Teva Pharmaceutical Industries
Given Imaging Ltd.
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00731172
First received: August 6, 2008
Last updated: March 1, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2011
  Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)